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Abstract
Background: Depression is a common and disabling condition. In Chile, assistance is guaranteed by law through a
national program for depression in primary care services, and there is evidence of effective treatment for depressed
women. However, there is a shortage of evidence-based treatments for depression in adolescents. The incorporation of
technology to expand therapeutic options is becoming more common. This proposal aims to compare the efficacy of
therapy that enhances traditional face-to-face cognitive-behavioral therapy (CBT) with a computer-based program
versus usual care to treat depression in adolescents in primary care clinics in Santiago, Chile.
Methods and design: This is a two-arm, single-blind, randomized controlled trial with a target enrollment of 216
depressed adolescents between 15 and 19 years of age, attending four primary care clinics in Santiago, Chile. In the
active arm, depressed adolescents will receive eight sessions of computer-assisted CBT, led by trained psychologists on
a weekly basis. In the control arm, depressed adolescents will receive treatment as usual from the primary care centers.
Mean depression scores and indicators of dysfunctional thoughts, problem-solving strategies, and health-related quality
of life will be measured at baseline and four and six months after randomization.
Discussion: As far as we know, this is the first randomized controlled trial of a computer-assisted CBT intervention for
depressed adolescents in a Latin American country.
Trial registration: Clinical Trials: NCT01862913
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Background
Depression is a global public health concern, as it is a
highly prevalent and recurrent condition that affects
people of all ages and carries high individual, family, and
social costs [1]. It is currently a leading cause of burden
worldwide, measured in terms of disability-adjusted life
years [2].
Key epidemiological studies have investigated the burden
of depression in the Chilean general population [3,4], and
in recent years, research has reported a high prevalence
of depression in adolescents between the ages of 12
and 18 [5].
To address the needs of the population, a National
Depression Detection and Treatment Program in Chilean
Primary Care was first introduced in 2001, consisting of
a stepped care program that combines medical and psy-
chosocial interventions, as well as improved detection,
diagnosis, treatment, and follow-up of each case [6,7].
In 2006, the treatment of depressive episodes, recurrent
depressive disorder, and depressive episodes of bipolar
disorder was strengthened with the introduction of the
Regime of Explicit Health Guarantees (AUGE) [8]. This
plan ensures access to opportune, quality, and financially
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protected depression treatment for all persons 15 years of
age and older. In this plan, the primary care teams play a
leading role in the management of depression. The AUGE
Clinical Guidelines for Depression treatment in primary
care include pharmacological treatment, medical controls,
psychosocial interventions, and referral to secondary or
tertiary psychiatric services, depending on the specificities
of each case [9]. Additionally, it is important to note
that, in Chile, there is evidence of effective psychosocial
treatments based in primary care centers for depressed
low-income women and for mothers affected by depression
during the postnatal period [10,11].
International studies have shown that adolescent de-
pression is strongly linked to clinical and social morbidity
[12,13]. However, although several systematic reviews have
demonstrated the efficacy of cognitive-behavioral therapy
(CBT) interventions [14,15], there has been little or no
research into adolescent depression treatment options
in Chile. One way to increase the appeal of CBT for
adolescents could be to use computer-assisted therapy.
This is especially important in primary care centers where
CBT for adolescents with depression in routine clinical
practice is limited [16]. Eells et al. define computer-
assisted psychotherapy as a ‘psychosocial treatment in
which a significant portion of the content is delivered
with the use of computer technology or in which the
computer technology assists the work of a therapist’ [17].
The incorporation of technology to expand therapeutic
options is becoming more common. Computer-based or
online programs have proven efficacy in the treatment
of adults [18,19], although the outcomes in adolescents
remain unclear [20]. A pilot study has shown that
adolescents could be motivated by the incorporation of
technology into therapeutic sessions at their homes,
guided by a professional who is not a CBT therapist,
though the sample size of this study is quite low [21].
There has yet to be a randomized controlled trial to
evaluate a procedure that enhances traditional face-to-
face CBT with a computer program for adolescents in
primary care centers.
Adding a computer-based component to face-to-face
psychotherapy sessions may further favor the acceptance
and incorporation of CBT therapy techniques. This
combination would take advantage of the strengths of
each approach: (1) the multi-media program could bet-
ter hold the attention of the adolescents, while providing
them with more stimuli and therefore an enhanced
learning experience; and (2) the presence of a clinician
permits the development of a therapeutic bond and
allows for the tailoring of the program to the individual
case. Furthermore, a systematic review and meta-analysis
found that when computer-assisted therapy was combined
with clinician support, the dropout rate was significantly
lower than it was for programs without the presence of
the therapist (28% versus 74%) [18]. For these reasons, we
believe that the use of a computer-assisted CBT program,
delivered in person by trained therapists, is a promising
way to deliver these treatments among adolescents.
Methods and design
This is a two-arm, single-blind (blinded only to outcome
assessor), individually randomized controlled trial, which
will compare the efficacy of computer-assisted CBT versus
usual treatment for depression in adolescents in primary
care clinics in Santiago, Chile.
Aims and hypotheses
General aim
To carry out a randomized controlled trial to compare
the efficacy of a computer-assisted CBT intervention
versus usual care to treat depression in adolescents in
primary care clinics in Santiago, Chile.
Specific aims
1. To compare the level of depressive symptoms of
adolescents suffering depression treated with
computer-assisted CBT versus usual care in primary
care clinics.
2. To compare the level of dysfunctional thoughts,
strategies for solving problems, and health-related
quality of life (HRQoL) of adolescents suffering de-
pression treated with computer-assisted CBT versus
usual care in primary care clinics.
3. To compare adolescents’ adherence to
computer-assisted CBT versus usual care in primary
care clinics.
4. To compare adolescents’ satisfaction with
computer-assisted CBT versus usual care in primary
care clinics.
Hypotheses
1. Adolescents receiving the intervention will achieve
lower scores (difference in mean of at least 0.4
standard deviations) in the depression questionnaire
than those receiving the usual care, four months
after randomization.
2. Adolescents receiving the intervention would
have fewer dysfunctional thoughts than those
receiving the usual care, four months after
randomization.
3. Adolescents receiving the intervention would be
better at solving problems than those receiving the
usual care, four months after randomization.
4. Adolescents receiving the intervention would have
better HRQoL than those receiving the usual care,
four months after randomization.
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5. Symptomatic improvements achieved at four
months after randomization will be maintained at
six months after randomization.
Setting and population
Adolescents between 15 and 19 years of age attending
four primary care clinics located in Puente Alto, a low-
income municipality of Santiago, Chile, with a large
adolescent population.
Inclusion and exclusion criteria
Depressed adolescents aged between 15 and 19 years
of age will be invited to participate. Informed consent
will be obtained from each participant over 18 years of
age, and from the parent or guardian of under-age
participants. In the case of the latter, informed assent
from the participants will also be required to continue
with the study. Depression will be assessed with the Beck
Depression Inventory (BDI) [22]. Adolescents scoring
ten or more points on the BDI will be invited to a
semi-structured diagnostic interview that includes the
Kiddie-SADS-Present and Lifetime Version interview
(K-SADS-PL) [23] to assess other inclusion criteria
(diagnostic criteria for depressive disorders) and to
ensure that they do not meet the exclusion criteria
(current suicidal risk requiring in-patient care, current
psychosis, alcohol or substance dependence, or low
intellectual ability). Those taking antidepressants or
receiving psychotherapy, and those with a history of
bipolar illness, will also be excluded. The K-SADS-PL
interview will be conducted with all potential partici-
pants by the principal investigator (VM), who is a child
and adolescent psychiatrist, or a clinical psychologist, who
have both been certified in conducting the interview.
Training of primary care center professionals
Before the start of recruitment, professionals in the four
participating primary care centers will receive a special
training session from the principal investigator (VM) to
assist with the correct identification, diagnosis, and treat-
ment of patients with depression, according to the AUGE
Clinical Guidelines for Depression. There will also be a
refresher session 6 months after the start of recruitment.
Intervention arm
The intervention arm will receive eight sessions of
computer-assisted CBT plus usual medical treatment, as
described in the AUGE Clinical Guidelines for Depression.
Computer-assisted CBT sessions will be delivered on a
weekly basis and assisted by trained psychologists in
face-to-face meetings. The program is called ‘Yo pienso,
siento y actúo mejor’ (YPSA-M); in English, ‘I think,
feel, and behave better’. Topics covered in the program
will include information on symptoms and causes of
depression, treatment options, problem-solving techniques
and other cognitive-orientated strategies to challenge
negative thoughts. Copies of the computerized program
are available upon written request to the principal investi-
gator (VM).
Psychologists delivering the intervention will receive
12 hours of training and will be supervised by the study
principal investigator (VM) once a month, and upon
request.
Between sessions, members of the study team will
contact the participants to remind them of upcoming
appointments in the intervention arm.
Control arm
The control arm will receive treatment as usual from the
primary care clinics. The professionals in the primary
care centers will be instructed to follow the AUGE
Clinical Guidelines for Depression.
Outcome measures
Primary outcome measures
Depressive symptoms will be assessed as a primary out-
come using the BDI as a continuous variable. This in-
ventory is designed to evaluate depressive symptoms in
adults and adolescents from the age of 13. The BDI is a
brief and well-established depression questionnaire
translated into different languages and used widely
throughout the world. It has shown good psychometric
properties [22]. It has previously been used in primary
care settings in Chile [24].
Secondary outcome measures
The Children’s Automatic Thoughts Scale is a self-
reporting questionnaire to evaluate dysfunctional thoughts
of children and adolescents. Internal consistency of the
subscales is high, and the test-retest reliability is adequate
[25]. The ‘personal failure’ subscale will be used as a
secondary outcome measure. This subscale was chosen
because it is most closely associated with depression. It
has ten items. Each item is given a score of between 0
and 4 points and thus the total score varies between 0
and 40. Highest scores show a greater presence of negative
automatic thoughts. In the validation study, this subscale
discriminated well between the community sample and
the sample of depressed individuals; the Cronbach’s alpha
coefficient was 0.92. The test-retest correlation coefficient
was 0.80 at one month and 0.74 at three months. The
mean score in a non-clinical sample was 6.48 (standard
deviation = 7.20) [25].
The Social Problem-Solving Inventory - Revised Short
Form is a self-reporting questionnaire with 25 items. It
consists of five subscales with five items each. Two of
these subscales, ‘positive problem orientation’ and ‘negative
problem orientation’, assess functional and dysfunctional
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cognitive and emotional orientations towards solving
problems. The three remaining subscales, ‘rational problem
solving’, ‘impulsivity-carelessness style’, and ‘avoidance style’,
assess problem-solving skills and behavioral style. The total
score of this scale varies between 0 and 20 points. Highest
scores correspond to better social problem-solving abilities
[26]. Calvete and Cardeñoso [27] used a Spanish version
that had good psychometric properties and had been used
in Chile. Cronbach’s alpha coefficient varied between 0.64
and 0.82 in the different subscales [27].
The KIDSCREEN-27 is a HRQoL questionnaire and
consists of 27 items pertaining aspects of the child’s
physical wellbeing, mood, autonomy, satisfaction with
parental relationship and the atmosphere at home, per-
ceived nature of the respondents’ relationships with
other children or adolescents and perceptions of his or
her cognitive capacity, learning and concentration, and
his or her feelings about school. The KIDSCREEN items
assess either the frequency of certain behaviors or feelings
(never, seldom, sometimes, often, always) or, in fewer
cases, the intensity of an attitude (not at all, slightly,
moderately, very, extremely). The recall period is one
week. For the scoring and analysis, negatively worded
items will be recoded so that for all items, higher scores
indicate a better HRQoL [28]. The KIDSCREEN has
been validated in Chile [29].
Other outcomes
The attendance of participants in both study arms to
programmed appointments will be monitored, to evaluate
treatment adherence. Additionally, satisfaction with treat-
ment will be measured with a self-report questionnaire,
six months after the baseline assessment.
Sample size
We anticipate that the intervention, will produce a clin-
ically meaningful improvement (remission) in 60% of
adolescents and only 40% of those in usual care will reach
this level of improvement in four months. A difference of
20% will be regarded as worth detecting and clinically
meaningful. For a two-sided alpha coefficient of 5% and a
statistical power of 80%, 97 adolescents will be needed in
each group to detect this difference, or 108 subjects per
group, allowing for 10% attrition. This total also yields an
80% power to detect a difference in mean of at least 0.4
standard deviations in the primary outcome measure.
Recruitment
Adolescents eligible for the study will be identified by
health professionals of the four primary care clinics, as
well as by psychologists and counselors of nearby schools,
who will be informed of the study, trained to identify
potential cases of depression among their students, and
instructed to refer any adolescent who seems to have
depression symptoms to the primary care clinics for
further evaluation and possible participation in the
study, according to inclusion and exclusion criteria.
Group assignment
Those adolescents who at baseline assessment meet the
inclusion criteria and do not meet the exclusion criteria
will be randomly assigned to the intervention arm or
to the control arm. Blocked (size of four), stratified
randomization will be used. Stratification will be im-
plemented regarding sex and severity of depression
(mild, moderate, and severe) according to BDI score.
Randomization will be generated using web-based random
allocation algorithms. Allocation concealment will be car-
ried out by keeping treatment assignment in numbered
sealed envelopes in a central place; the envelopes will
be opened by individuals who do not participate in the
recruitment process.
Data collection
All participants will be assessed at baseline and at four
and six months after randomization. The instruments
that will be used are all self-report questionnaires, which
will be completed on paper by the participants. Trained
psychologists who are blind to the group assignments
will be present to assist the adolescents if necessary.
Data management
After the participants have completed the questionnaires,
the data will entered into a secure platform, without
identifying information (each participant will be assigned
an ID number). The original copies of the instruments will
be filed and stored, under lock and key, in the principal
investigator’s office, along with the list linking the
participants’ names and ID numbers. Only two research
assistants, in charge of data entry, and the statistician
will have access to the database.
Data analysis
Data and presentation of the results will be in accordance
with CONSORT guidelines for randomized clinical trials,
with the primary comparative analysis being conducted
on an intention-to-treat basis. Initially, we will conduct
descriptive analysis to assess the balance between the two
groups. The primary analysis will employ multivariable
linear regression to investigate differences in mean symp-
tom scores (primary outcome measure) between groups at
four months after randomization, adjusting for baseline
outcome variable if imbalances are identified. Sensitivity
analysis making different assumptions will be conducted
to investigate the potential effects of missing data. Similar
analyses will be conducted for the secondary outcome
measures.
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Monitoring
The primary care center staff will be told to report any
type of adverse event (for example, hospitalization, preg-
nancy, suicide attempt) affecting the participants to the
principal investigator, who will then take appropriate
measures to ensure the safety and wellbeing of the
participants.
Research governance and ethics
Trial management
The study will comply with local Research Governance
requirements.
Ethics
Full ethical approval was obtained from the local Commit-
tee (Faculty of Medicine, Universidad de Chile, project
number 032-2012). Informed and written consent will be
obtained from the participants 18 years of age or older,
while for adolescents younger than 18 years of age, their
parents’ informed consent will be required, along with the
informed assent of the participants.
Discussion
As far as we know, this is the first randomized controlled
trial of a computer-assisted CBT intervention for depressed
adolescents in a Latin American country. We believe that
the use of the computerized program YPSA-M, coupled
with face-to-face CBT, will enhance the therapeutic effects
in the intervention participants, compared with the control
arm. Past experience has shown that it may be difficult
to recruit and sufficiently motivate adolescents to attend
psychosocial interventions, given their school schedules
and the social stigma associated with mental health
treatment [15]. Nevertheless, we hope that the use of
the computerized program will be appealing, and that
we will receive support from the centers, schools, and
parents for successful implementation of the program.
It is important to highlight that although the AUGE
Clinical Guidelines for Depression recommend the use
of psychosocial interventions to treat depression, there
is currently no evidence-based intervention available for
this age group in Chile. Our intervention could provide an
effective psychosocial tool, and primary care psychologists
could easily be trained to apply the program.
Trial status
The study started recruiting patients in July 2013.
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